AR043622A1 - "2- (butil-1 sulfonilamino) - n- [1 (r) - (6 - metoxipiridin - 3 - il - propil] benzamida ,su uso como un medicamento y preparaciones farmaceuticas que lo comprenden - Google Patents
"2- (butil-1 sulfonilamino) - n- [1 (r) - (6 - metoxipiridin - 3 - il - propil] benzamida ,su uso como un medicamento y preparaciones farmaceuticas que lo comprendenInfo
- Publication number
- AR043622A1 AR043622A1 ARP040100866A ARP040100866A AR043622A1 AR 043622 A1 AR043622 A1 AR 043622A1 AR P040100866 A ARP040100866 A AR P040100866A AR P040100866 A ARP040100866 A AR P040100866A AR 043622 A1 AR043622 A1 AR 043622A1
- Authority
- AR
- Argentina
- Prior art keywords
- metoxipiridin
- benzamida
- propil
- butil
- sulfonylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043622A1 true AR043622A1 (es) | 2005-08-03 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100866A AR043622A1 (es) | 2003-03-18 | 2004-03-16 | "2- (butil-1 sulfonilamino) - n- [1 (r) - (6 - metoxipiridin - 3 - il - propil] benzamida ,su uso como un medicamento y preparaciones farmaceuticas que lo comprenden |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (de) |
| JP (1) | JP2006520343A (de) |
| KR (1) | KR20050110681A (de) |
| CN (1) | CN100361943C (de) |
| AR (1) | AR043622A1 (de) |
| AU (1) | AU2004222137A1 (de) |
| BR (1) | BRPI0408441A (de) |
| CA (1) | CA2519022A1 (de) |
| DE (1) | DE10312073A1 (de) |
| HK (1) | HK1086819A1 (de) |
| HR (1) | HRP20050815A2 (de) |
| MA (1) | MA27749A1 (de) |
| MX (1) | MXPA05009763A (de) |
| MY (1) | MY176510A (de) |
| NO (1) | NO20054472L (de) |
| NZ (1) | NZ542476A (de) |
| PE (1) | PE20050307A1 (de) |
| RS (1) | RS20050690A (de) |
| RU (1) | RU2333202C2 (de) |
| TW (1) | TW200500342A (de) |
| WO (1) | WO2004083157A1 (de) |
| ZA (1) | ZA200506328B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| US8278317B2 (en) * | 2005-07-22 | 2012-10-02 | Merck Sharp & Dohme Corp. | Potassium channel inhibitors |
| JP5685203B2 (ja) * | 2009-05-29 | 2015-03-18 | ラクオリア創薬株式会社 | カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de active Application Filing
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Application Discontinuation
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-16 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
-
2006
- 2006-06-16 HK HK06106891A patent/HK1086819A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050815A2 (en) | 2006-09-30 |
| AU2004222137A1 (en) | 2004-09-30 |
| CA2519022A1 (en) | 2004-09-30 |
| TW200500342A (en) | 2005-01-01 |
| DE10312073A1 (de) | 2004-09-30 |
| PE20050307A1 (es) | 2005-06-08 |
| ZA200506328B (en) | 2006-04-26 |
| CN100361943C (zh) | 2008-01-16 |
| RU2005132163A (ru) | 2006-04-10 |
| HK1086819A1 (en) | 2006-09-29 |
| CN1756728A (zh) | 2006-04-05 |
| JP2006520343A (ja) | 2006-09-07 |
| MY176510A (en) | 2020-08-12 |
| MA27749A1 (fr) | 2006-02-01 |
| NZ542476A (en) | 2008-05-30 |
| MXPA05009763A (es) | 2006-01-27 |
| RS20050690A (sr) | 2008-04-04 |
| RU2333202C2 (ru) | 2008-09-10 |
| NO20054472L (no) | 2005-09-27 |
| BRPI0408441A (pt) | 2006-04-04 |
| WO2004083157A1 (de) | 2004-09-30 |
| KR20050110681A (ko) | 2005-11-23 |
| EP1606237A1 (de) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR031430A1 (es) | Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen | |
| BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
| BRPI0113146B8 (pt) | "derivados de prolina e composição farmacêutica que os compreende". | |
| ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| BRPI0108395B8 (pt) | derivados de pirrolopirimidinona, processos de preparação e uso | |
| PA8547701A1 (es) | Nucleosidos 4 substituidos. | |
| UY28510A1 (es) | Compuestos quimicos | |
| AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| BRPI0412291A (pt) | antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia | |
| BRPI0411891A (pt) | pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3 | |
| BRPI0607214B8 (pt) | derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| BR0307588A (pt) | Composto, inibidor de gsk-3, composição farmacêutica, e, agente terapêutico ou preventivo para uma doença | |
| ES2163735T3 (es) | Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| GT200800066A (es) | Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento. | |
| BR0103048A (pt) | Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |